PEQCX
Price
$36.79
Change
+$0.21 (+0.57%)
Updated
Jul 3 closing price
Net Assets
39.89B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

PEQCX vs VIVAX

Header iconPEQCX vs VIVAX Comparison
Open Charts PEQCX vs VIVAXBanner chart's image
Putnam Large Cap Value C
Price$36.79
Change+$0.21 (+0.57%)
VolumeN/A
Net Assets39.89B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
PEQCX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PEQCX vs. VIVAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEQCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. PEQCX (39.9B). VIVAX pays higher dividends than PEQCX: VIVAX (2.06) vs PEQCX (0.35). PEQCX was incepted earlier than VIVAX: PEQCX (26 years) vs VIVAX (33 years). PEQCX (1.63) is less costly to investors than VIVAX (0.17). PEQCX is a more actively managed with annual turnover of: 16.00 vs. VIVAX (9.00). PEQCX has a lower initial minimum investment than VIVAX: PEQCX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. PEQCX (7.28). VIVAX return over 5 years is better than : 80.14 vs. PEQCX (65.18).
PEQCXVIVAXPEQCX / VIVAX
Total Expense Ratio1.630.17959%
Annual Report Gross Expense Ratio1.630.17959%
Fund Existence26 years33 years-
Gain YTD8.8296.209142%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets39.9B189B21%
Annual Yield % from dividends0.352.0617%
Returns for 1 year7.2812.0460%
Returns for 3 years34.5035.1698%
Returns for 5 years65.1880.1481%
Returns for 10 years83.64115.7472%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.